-0.360 (-3.98%)
Range 8.540 - 9.200   (7.73%)
Open 9.000
Previous Close 9.040
Buy Price 8.660
Buy Volume 8
Sell Price 8.680
Sell Volume 8
Volume 901,195
Value -
Measurement Type Value
EPS (USD) -0.298
Trailing EPS (USD) -0.298
NAV (USD) 0.246
Cash In Hand (USD) 0.25
Dividend -
Dividend Yield (%) -
PE -
Trailing PE -
Price / NAV 36.748
Price / Cash In Hand 36.146
Issued & Paid-up Shares 66,757,300
Treasury Shares -
Market Cap (M) 603.486
Par Value (USD) n.a.
Beta - 75 Days -0.958
R-Squared - 75 Days(%) 1.62
Beta - 500 Days 0.465
R-Squared - 500 Days(%) 1.61
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 15 Apr 2021 04:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.


Release Date 11 May 2021
View All Events


Chromadex Corporation is a provider of research and quality-control products and services to the natural products industry. The Company is a natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its business model that utilizes its wholly owned synergistic business units, including ingredient technologies, natural product fine chemicals (known as phytochemicals), chemistry and analytical testing services, and product regulatory and safety consulting. The Company provides science-based solutions to the nutritional supplement, food and beverage, animal health, cosmetic and pharmaceutical industries. Through its subsidiaries Chromadex Analytics, Inc. and Spherix Consulting, Inc., the Company performs chemistry-based analytical services and offers scientific and regulatory consulting, respectively.

Loading Chart...